KIAA1219 Inhibitors
Inhibitors of KIAA1219 function by disrupting the signaling pathways and cellular processes that govern its activity. For instance, inhibition of protein kinases that phosphorylate KIAA1219 results in its decreased phosphorylation, which is essential for its functional activity. The suppression of mTOR signaling, which is crucial for protein synthesis, similarly leads to a reduction in KIAA1219 function because KIAA1219's activity is contingent on the protein synthesis machinery. Inhibitors that target the PI3K/Akt and ERK/MAPK pathways also play a pivotal role in diminishing KIAA1219 function. These inhibitors attenuate the signaling cascades that KIAA1219 relies on, thereby leading to a reduction in its activity.
Furthermore, the functional inhibition of KIAA1219 extends to the manipulation of cellular structures and additional signaling molecules that are integral to its activity. Agents that disrupt Golgi apparatus function impede processes that are potentially vital for KIAA1219's activity, leading to its decreased function. Similarly, immunosuppressants that inhibit calcineurin also contribute to the reduction of KIAA1219 activity, as calcineurin-mediated signaling may be necessary for KIAA1219's function. Additionally, the inhibition of protein phosphatases that would usually act to dephosphorylate KIAA1219 results in its sustained phosphorylation state, thus reducing its activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent inhibitor of protein kinases. KIAA1219’s activity is influenced by phosphorylation; staurosporine inhibits this process by targeting the kinases responsible for KIAA1219 phosphorylation, leading to decreased phosphorylation and subsequent activity of KIAA1219. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor which can affect protein synthesis. As KIAA1219 function is dependent on protein synthesis pathways, rapamycin indirectly reduces KIAA1219 function by hindering the protein synthesis machinery that is required for its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor which indirectly affects KIAA1219 by reducing PI3K/Akt signaling, a pathway that KIAA1219 may be involved in for its proper localization and function. Reduced PI3K signaling decreases KIAA1219 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A specific inhibitor of MEK, which in turn inhibits ERK/MAPK pathway. KIAA1219, which may be regulated by the MAPK signaling pathway, thus experiences reduced activity due to diminished downstream signaling as a result of MEK inhibition. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor which impacts KIAA1219 activity by inhibiting the p38 MAPK pathway that contributes to the regulation of KIAA1219 function. This leads to a decrease in the functional activity of KIAA1219. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Another MEK inhibitor that causes reduced ERK phosphorylation. By inhibiting MEK, the downstream effects on the MAPK pathway reduce the activity of proteins like KIAA1219 that rely on this pathway for full activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor that leads to a reduction in Akt signaling, which may regulate KIAA1219 activity. This inhibition results in decreased function of KIAA1219 due to the reliance of KIAA1219 on PI3K/Akt pathway for its activity. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
An inhibitor of ADP-ribosylation factor (Arf), which disrupts Golgi structure and function. KIAA1219, which may be involved in Golgi-related processes, would have decreased functional activity due to the disruption caused by Brefeldin A. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressant that inhibits calcineurin. As KIAA1219’s activity may be modulated by calcium/calcineurin signaling, inhibition of calcineurin could lead to reduced functional activity of KIAA1219. | ||||||
Endothall | 145-73-3 | sc-201325 sc-201325A | 20 mg 100 mg | $49.00 $203.00 | 1 | |
Inhibits protein phosphatases 1 and 2A. Since KIAA1219 may be regulated by dephosphorylation events mediated by these phosphatases, endothall would inhibit the dephosphorylation, thus decreasing KIAA1219 activity. | ||||||